PRODUCT DETAILS

About Advamab 400 Injection

BEVACIZUMAB is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.

BEVACIZUMAB contains 'Bevacizumab' that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.

Uses of Advamab 400 Injection

Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum

Medicinal Benefits of Advamab 400 Injection

BEVACIZUMAB contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. BEVACIZUMAB works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.

Directions for Use

BEVACIZUMAB will be administered by a healthcare professional; do not self-administer.

Side Effects of Advamab 400 Injection

• Constipation
• Loss of appetite
• Fever
• Nose bleeds
• Change in speech
• Change in taste
• Voice changes/hoarseness
• Loss of body weight

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

BEVACIZUMAB should only be taken under medical supervision. While taking BEVACIZUMAB, the doctor will monitor your condition on a regular basis. If you have a history of allergic reactions to BEVACIZUMAB or other medications, inform your doctor before taking it. Avoid taking BEVACIZUMAB if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. BEVACIZUMAB may cause sleepiness and fainting, so avoid driving while on treatment with BEVACIZUMAB. Inform your doctor if you have/had high blood pressure, heart attack, stroke, bleeding problems, stomach/intestinal bleeding, perforation; if you had surgery in the past 28days/are due to have surgery. Do not breastfeed during the treatment and for 6months after the last dose of BEVACIZUMAB. While taking BEVACIZUMAB, please do not get any immunizations or vaccinations unless your doctor has approved it. BEVACIZUMAB may increase the risk of bleeding, so be cautious and consult your doctor if you notice any bleeding or bruising.

Drug-Drug Interaction:

BEVACIZUMAB may have interaction with a drug used to treat renal and gastrointestinal cancer (sunitinib) and platinum or taxane-based therapies for lung or metastatic breast cancer. Inform your doctor if you have recently received, or are receiving, radiotherapy.